HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mamoru Nango Selected Research

Triethylenephosphoramide (TEPA)

1/2015Susceptibility of PTEN-positive metastatic tumors to small interfering RNA targeting the mammalian target of rapamycin.
6/2012RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment.
3/2011Dicetyl phosphate-tetraethylenepentamine-based liposomes for systemic siRNA delivery.
1/2011Inhibition of Akt (ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mamoru Nango Research Topics

Disease

8Neoplasms (Cancer)
01/2015 - 01/2002
5Melanoma (Melanoma, Malignant)
01/2015 - 03/2011
2Fibrosarcoma
02/2014 - 03/2011
2Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature
06/2008 - 08/2007
2Photosensitivity Disorders (Photodermatitis)
06/2004 - 04/2003
1Carcinoma (Carcinomatosis)
03/2011
1Rupture
06/2006
1Phototoxic Dermatitis (Phototoxicity)
07/2003
1Sarcoma (Soft Tissue Sarcoma)
04/2003

Drug/Important Bio-Agent (IBA)

6Small Interfering RNA (siRNA)IBA
01/2015 - 01/2011
6Liposomes (Liposome)IBA
01/2013 - 04/2003
4Triethylenephosphoramide (TEPA)IBA
01/2015 - 01/2011
4Photosensitizing Agents (Photosensitizers)IBA
06/2004 - 01/2002
3LuciferasesIBA
02/2014 - 03/2011
3Peptides (Polypeptides)IBA
01/2013 - 01/2011
3CholesterolIBA
01/2013 - 03/2011
3Verteporfin (Visudyne)FDA Link
06/2004 - 04/2003
31-phenyl-3,3-dimethyltriazene (PDT)IBA
06/2004 - 04/2003
2TOR Serine-Threonine KinasesIBA
01/2015 - 01/2011
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
01/2013 - 06/2012
2alanyl-prolyl-arginyl-prolyl-glycineIBA
03/2011 - 01/2011
2GoldIBA
06/2008 - 08/2007
1Sirolimus (Rapamycin)FDA Link
01/2015
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
02/2014
1enhanced green fluorescent proteinIBA
02/2014
1arginyl-glycyl-aspartic acidIBA
01/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2013
11,2-distearoylphosphatidylethanolamine (DSPE)IBA
06/2012
1cyclic arginine-glycine-aspartic acid peptideIBA
06/2012
1Mechanistic Target of Rapamycin Complex 1IBA
01/2011
1Mechanistic Target of Rapamycin Complex 2IBA
01/2011
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2011
1Carboxylic AcidsIBA
08/2007
11,2- dioleoyl- sn- glycero- 3- phosphoglycerol (DOPG)IBA
06/2006
1Glycerol (Glycerine)FDA LinkGeneric
06/2006
1distearoyl phosphatidylglycerol (DSPG)IBA
06/2006
1Lipid Bilayers (Lipid Bilayer)IBA
06/2006
1Rhodamine 123IBA
06/2004
1PolyethyleneimineIBA
06/2004

Therapy/Procedure

3Photochemotherapy (Photodynamic Therapy)
06/2004 - 01/2002
2Intravenous Injections
01/2015 - 06/2012
2Therapeutics
01/2013 - 01/2011
2Electrodes (Electrode)
06/2008 - 08/2007
1RNAi Therapeutics
06/2012
1Lasers (Laser)
06/2004
1Subcutaneous Injections
04/2003